Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822768 · ClinicalTrials.gov registry record · NA
Packing Versus no Packing for Cutaneous Abscess
A NA study of Cutaneous Abscess, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 196
- Enrollment target
- 1
- Study location
NCT02822768 is a NA study of Cutaneous Abscess that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 196 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02822768, a NA study of Cutaneous Abscess, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further interventions such as repeat incision and drainage, antibiotic administration or hospital admission.
Conditions Studied
Interventions
- PROCEDURE Packing
- OTHER No packing
Study Locations (1)
California
- Community Regional Medical Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2016-08 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02822768
The ClinicalTrials.gov registry entry for NCT02822768 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cutaneous Abscess appearing as the primary indexed condition, and to 2 interventions - of which Packing is the first listed.
NCT02822768 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02822768 about?
NCT02822768 is a clinical study titled "Packing Versus no Packing for Cutaneous Abscess". The goal of this study is to examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further interventions such as repeat incision and drainage, antibiotic administration or hospital admission.
What is the current status of trial NCT02822768?
This trial is currently recruiting. It is a NA study. The enrollment target is 196 participants. The study started on 2016-08. Estimated completion is 2026-04.
What conditions does trial NCT02822768 study?
This clinical trial studies the following conditions: Cutaneous Abscess.
What interventions are being tested in trial NCT02822768?
The interventions under investigation include: Packing (PROCEDURE), No packing (OTHER).
Who is sponsoring clinical trial NCT02822768?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02822768 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.